Where should we focus?
Competitive
landscapes
Compare assets, indications, and competitors. Understand the evidence behind the opportunity.
Asset landscapes · Gap analysis · Portfolio intelligenceStrategic intelligence for biopharma
Competitive landscapes, target product profiles, and conference intelligence for biopharma decisions.
Our AI agents and scientists work over the same connected evidence, with experts shaping the analysis throughout.
Our clients already include 4 of the largest pharmaceutical companies.
01 / Our analysis
More evidence, sooner. More options before you commit. Start with the question your team needs to answer.
Where should we focus?
Compare assets, indications, and competitors. Understand the evidence behind the opportunity.
Asset landscapes · Gap analysis · Portfolio intelligenceHow will we differentiate?
Define your product against clinical and commercial benchmarks, with the reasoning made clear.
Clinical benchmarks · Target positioning · Evidence reviewWhat changes our strategy?
Know what changed and what it means. Put new evidence in the context of your competitive landscape.
Conference readiness · Evidence updates · Strategic briefings03 / In practice
From a single strategic question to ongoing portfolio intelligence. Here is what that looks like in practice.
Conference intelligence
Readiness and evidence updates for a top-20 pharma company.
Target product profiles
A top-20 pharma pilot expanded into a multi-phase program.
Competitive intelligence
An oncology landscape grew into ongoing portfolio intelligence.
Results from individual engagements. Timing depends on scope, evidence availability, and scientific review.
Your next decision starts here
Bring us your question. Let’s define the analysis that moves you forward.